生物药物-话题@MedSci - 梅斯（MedSci）

#生物药物#

14篇内容 | 1106人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1992747, encodeId=53f71992e47f2, content=<a href='/topic/show?id=9bcf694523a' target=_blank style='color:#2F92EE;'>#生物药物#</a>, objectTitle=ARD：EULAR指出考虑在炎症性风湿病和肌肉骨骼疾病中对生物药物进行治疗药物监测, objectType=article, longId=728123, objectId=b0e0e281237f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b0e0e281237f, replyNumber=0, likeNumber=93, createdTime=2022-06-25, rootId=0, userName=hittouch, userId=dc4b2500077, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b0e0e281237f, moduleTitle=ARD：EULAR指出考虑在炎症性风湿病和肌肉骨骼疾病中对生物药物进行治疗药物监测, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b0e0e281237f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1992746, encodeId=fa241992e4689, content=<a href='/topic/show?id=9bcf694523a' target=_blank style='color:#2F92EE;'>#生物药物#</a>, objectTitle=生物药物治疗银屑病的依从性和持久性研究, objectType=article, longId=725656, objectId=41eae2565659, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=41eae2565659, replyNumber=0, likeNumber=103, createdTime=2022-09-13, rootId=0, userName=hittouch, userId=dc4b2500077, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=41eae2565659, moduleTitle=生物药物治疗银屑病的依从性和持久性研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=41eae2565659)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1992745, encodeId=5b421992e45f5, content=<a href='/topic/show?id=9bcf694523a' target=_blank style='color:#2F92EE;'>#生物药物#</a>, objectTitle=JEADV：抗SARS-CoV-2BNT162b2疫苗在生物药物治疗银屑病中的免疫原性和安全性, objectType=article, longId=292961, objectId=bfce29296133, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bfce29296133, replyNumber=0, likeNumber=89, createdTime=2022-02-21, rootId=0, userName=hittouch, userId=dc4b2500077, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bfce29296133, moduleTitle=JEADV：抗SARS-CoV-2BNT162b2疫苗在生物药物治疗银屑病中的免疫原性和安全性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=bfce29296133)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1992743, encodeId=ed401992e43e7, content=<a href='/topic/show?id=9bcf694523a' target=_blank style='color:#2F92EE;'>#生物药物#</a>, objectTitle=DCR: 行结肠切除术的溃疡性结肠炎患者中使用生物药物不会增加术后并发症, objectType=article, longId=203225, objectId=9f2b2032252d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f2b2032252d, replyNumber=0, likeNumber=79, createdTime=2021-02-01, rootId=0, userName=hittouch, userId=dc4b2500077, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f2b2032252d, moduleTitle=DCR: 行结肠切除术的溃疡性结肠炎患者中使用生物药物不会增加术后并发症, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9f2b2032252d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1992744, encodeId=1fb11992e44bd, content=<a href='/topic/show?id=9bcf694523a' target=_blank style='color:#2F92EE;'>#生物药物#</a>, objectTitle=合成生物药物可利霉素（Carrimycin）治疗COVID-19：FDA已允许开展III期临床试验, objectType=article, longId=205036, objectId=8f5c20503649, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f5c20503649, replyNumber=0, likeNumber=82, createdTime=2021-01-23, rootId=0, userName=hittouch, userId=dc4b2500077, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f5c20503649, moduleTitle=合成生物药物可利霉素（Carrimycin）治疗COVID-19：FDA已允许开展III期临床试验, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=8f5c20503649)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1992742, encodeId=18e81992e421f, content=<a href='/topic/show?id=9bcf694523a' target=_blank style='color:#2F92EE;'>#生物药物#</a>, objectTitle=BMJ：不同生物药物联合甲氨蝶呤治疗类风湿关节炎的疗效差异研究, objectType=article, longId=197377, objectId=c1ab19e3772b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c1ab19e3772b, replyNumber=0, likeNumber=116, createdTime=2021-06-06, rootId=0, userName=hittouch, userId=dc4b2500077, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c1ab19e3772b, moduleTitle=BMJ：不同生物药物联合甲氨蝶呤治疗类风湿关节炎的疗效差异研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c1ab19e3772b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1992741, encodeId=df941992e4144, content=<a href='/topic/show?id=9bcf694523a' target=_blank style='color:#2F92EE;'>#生物药物#</a>, objectTitle=世卫提醒：2019冠状病毒病大流行增加了抗微生物药物耐药性的威胁, objectType=article, longId=195263, objectId=b2d11952637b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2d11952637b, replyNumber=0, likeNumber=74, createdTime=2020-10-24, rootId=0, userName=hittouch, userId=dc4b2500077, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2d11952637b, moduleTitle=世卫提醒：2019冠状病毒病大流行增加了抗微生物药物耐药性的威胁, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b2d11952637b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1992740, encodeId=01a71992e40f6, content=<a href='/topic/show?id=9bcf694523a' target=_blank style='color:#2F92EE;'>#生物药物#</a>, objectTitle=CMAJ：降低IBD患者VTE风险：初始治疗TNF-α抑制剂vs非生物药物, objectType=article, longId=126993, objectId=90be1269935e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90be1269935e, replyNumber=0, likeNumber=87, createdTime=2018-10-09, rootId=0, userName=hittouch, userId=dc4b2500077, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90be1269935e, moduleTitle=CMAJ：降低IBD患者VTE风险：初始治疗TNF-α抑制剂vs非生物药物, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=90be1269935e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1992739, encodeId=c3501992e3933, content=<a href='/topic/show?id=9bcf694523a' target=_blank style='color:#2F92EE;'>#生物药物#</a>, objectTitle=欧委会通过抗微生物药物耐药行动计划, objectType=article, longId=115678, objectId=9c6e1156e8c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c6e1156e8c5, replyNumber=0, likeNumber=85, createdTime=2018-09-20, rootId=0, userName=hittouch, userId=dc4b2500077, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c6e1156e8c5, moduleTitle=欧委会通过抗微生物药物耐药行动计划, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9c6e1156e8c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1992738, encodeId=4d5d1992e3876, content=<a href='/topic/show?id=9bcf694523a' target=_blank style='color:#2F92EE;'>#生物药物#</a>, objectTitle=上海交通大学药学院朱建伟院长：自主创新是生物药物研发的根本道路, objectType=article, longId=75490, objectId=5e80e549096, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e80e549096, replyNumber=0, likeNumber=82, createdTime=2017-08-03, rootId=0, userName=hittouch, userId=dc4b2500077, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e80e549096, moduleTitle=上海交通大学药学院朱建伟院长：自主创新是生物药物研发的根本道路, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=5e80e549096)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1992737, encodeId=887c1992e370c, content=<a href='/topic/show?id=9bcf694523a' target=_blank style='color:#2F92EE;'>#生物药物#</a>, objectTitle=世卫组织通过抗微生物药物耐药性决议, objectType=article, longId=51273, objectId=b086512e33c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b086512e33c, replyNumber=0, likeNumber=114, createdTime=2015-12-04, rootId=0, userName=hittouch, userId=dc4b2500077, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b086512e33c, moduleTitle=世卫组织通过抗微生物药物耐药性决议, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b086512e33c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1992736, encodeId=54ed1992e360a, content=<a href='/topic/show?id=9bcf694523a' target=_blank style='color:#2F92EE;'>#生物药物#</a>, objectTitle=NICE支持三款生物药物用于溃疡性结肠炎, objectType=article, longId=44251, objectId=061d44251e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=061d44251e1, replyNumber=0, likeNumber=91, createdTime=2015-09-30, rootId=0, userName=hittouch, userId=dc4b2500077, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=061d44251e1, moduleTitle=NICE支持三款生物药物用于溃疡性结肠炎, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=061d44251e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1992734, encodeId=6bc01992e3494, content=<a href='/topic/show?id=9bcf694523a' target=_blank style='color:#2F92EE;'>#生物药物#</a>, objectTitle=Nature：揭秘微生物药物生产流水线, objectType=article, longId=36847, objectId=90eb3684eb7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90eb3684eb7, replyNumber=0, likeNumber=91, createdTime=2015-04-27, rootId=0, userName=hittouch, userId=dc4b2500077, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90eb3684eb7, moduleTitle=Nature：揭秘微生物药物生产流水线, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=90eb3684eb7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1992735, encodeId=55021992e3536, content=<a href='/topic/show?id=9bcf694523a' target=_blank style='color:#2F92EE;'>#生物药物#</a>, objectTitle=罗氏Avastin再获批 **用于晚期宫颈癌的生物药物, objectType=article, longId=43043, objectId=f21c43043db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f21c43043db, replyNumber=0, likeNumber=78, createdTime=2015-08-23, rootId=0, userName=hittouch, userId=dc4b2500077, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f21c43043db, moduleTitle=罗氏Avastin再获批 **用于晚期宫颈癌的生物药物, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f21c43043db)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

生物药物

2020-05-29

hittouch (审核中...)

前往app查看评论内容

#生物药物#

ARD：EULAR指出考虑在炎症性风湿病和肌肉骨骼疾病中对生物药物进行治疗药物监测

2022-06-25

hittouch (审核中...)

前往app查看评论内容

#生物药物#

生物药物治疗银屑病的依从性和持久性研究

2022-09-13

hittouch (审核中...)

前往app查看评论内容

#生物药物#

JEADV：抗SARS-CoV-2BNT162b2疫苗在生物药物治疗银屑病中的免疫原性和安全性

2022-02-21

hittouch (审核中...)

前往app查看评论内容

#生物药物#

DCR: 行结肠切除术的溃疡性结肠炎患者中使用生物药物不会增加术后并发症

2021-02-01

hittouch (审核中...)

前往app查看评论内容

#生物药物#

合成生物药物可利霉素（Carrimycin）治疗COVID-19：FDA已允许开展III期临床试验

2021-01-23

hittouch (审核中...)

前往app查看评论内容

#生物药物#

BMJ：不同生物药物联合甲氨蝶呤治疗类风湿关节炎的疗效差异研究

2021-06-06

hittouch (审核中...)

前往app查看评论内容

#生物药物#

世卫提醒：2019冠状病毒病大流行增加了抗微生物药物耐药性的威胁

2020-10-24

hittouch (审核中...)

前往app查看评论内容

#生物药物#

CMAJ：降低IBD患者VTE风险：初始治疗TNF-α抑制剂vs非生物药物

2018-10-09

hittouch (审核中...)

前往app查看评论内容

#生物药物#

欧委会通过抗微生物药物耐药行动计划

2018-09-20

hittouch (审核中...)

前往app查看评论内容

#生物药物#

上海交通大学药学院朱建伟院长：自主创新是生物药物研发的根本道路

2017-08-03

hittouch (审核中...)

前往app查看评论内容

#生物药物#

世卫组织通过抗微生物药物耐药性决议

2015-12-04

hittouch (审核中...)

前往app查看评论内容

#生物药物#

NICE支持三款生物药物用于溃疡性结肠炎

2015-09-30

hittouch (审核中...)

前往app查看评论内容

#生物药物#

Nature：揭秘微生物药物生产流水线

2015-04-27

hittouch (审核中...)

前往app查看评论内容

#生物药物#

罗氏Avastin再获批 **用于晚期宫颈癌的生物药物

2015-08-23

科室
- - 订阅+
  - 更多科室
工具
服务